Nature 2002, 420: 860–867.CrossRefPubMed 3. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G: Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006, 72: 1605–1621.CrossRefPubMed 4. Chettibi S, Ferguson MW: Inflammation: Basic Principles and Clinical Correlates. (Edited by: Gallin JI, Snyderman R). Williams and Wilkinson. Lipincott. Philadelphia 1999, 865–881. 5. Brigati C, Noonan DM, Albini A, Benelli R: Tumors

and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002, 19: 247–258.CrossRefPubMed 6. Mantovani A: Cancer: inflammation by MRT67307 mouse remote control. Nature 2005, 435: 752–753.CrossRefPubMed 7. Stout RD, Bottomly K: Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones, Failure of IL-4-producing (TH2) T SB-715992 purchase cell clones to activate effector function in macrophages. J Immunol 1989, 142: 760–765.PubMed 8. DeNardo DG, Coussens LM: Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007, 9: 212.CrossRefPubMed 9. Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003, 3: 422–433.CrossRefPubMed 10. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005, 9: 267–285.CrossRefPubMed 11. FK228 manufacturer Ono

M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008, 99: 1501–1506.CrossRefPubMed 12. Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7: 211–217.CrossRefPubMed 13. de Visser KE, Coussens LM: The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 2006, 13: 118–137.CrossRefPubMed 14. Dvorak HF: Tumors: wounds that do not heal. Similarities

between tumor stroma generation and wound healing. N Engl J Med 1986, 315: 1650–1659.CrossRefPubMed 15. Lin WW, Karin M: A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117: 1175–1183.CrossRefPubMed 16. Dranoff G: Tumour immunology: immune recognition and tumor protection. Curr Opin Immunol 2002, 14: 161–164.CrossRef 17. Karin M, Greten FR: NF-kappaB: linking inflammation and immunity to cancer development PAK5 and progression. Nat Rev Immunol 2005, 5: 749–759.CrossRefPubMed 18. Coussens LM, Werb Z: Inflammatory cells and cancer: think different! J Exp Med 2001, 193 (6) : F23-F26.CrossRefPubMed 19. Villanueva J, Herlyn M: Melanoma and the tumor microenvironment. Curr Oncol Rep 2008, 10: 439–446.CrossRefPubMed 20. Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE: Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 2003, 995: 151–61.CrossRefPubMed 21. Hofmann UB, Westphal JR, Van Muijen GN: Matrix metalloproteinases in human melanoma.